From: Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
Conditions
RCP (%)
t0
t2
t4–6
t24
1
97.5
96.1
88.0
2
98.5
98.0
91.5
3
98.9
98.4
93.0
4
97.3
96.8
93.7
5
97.0
98.8
95.5
94.1